1. Home
  2. PHGE vs SRM Comparison

PHGE vs SRM Comparison

Compare PHGE & SRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • SRM
  • Stock Information
  • Founded
  • PHGE 2015
  • SRM 1979
  • Country
  • PHGE Israel
  • SRM United States
  • Employees
  • PHGE N/A
  • SRM N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • SRM
  • Sector
  • PHGE Health Care
  • SRM
  • Exchange
  • PHGE Nasdaq
  • SRM Nasdaq
  • Market Cap
  • PHGE 11.0M
  • SRM 9.0M
  • IPO Year
  • PHGE N/A
  • SRM 2023
  • Fundamental
  • Price
  • PHGE $0.42
  • SRM $6.70
  • Analyst Decision
  • PHGE Strong Buy
  • SRM
  • Analyst Count
  • PHGE 1
  • SRM 0
  • Target Price
  • PHGE $15.00
  • SRM N/A
  • AVG Volume (30 Days)
  • PHGE 265.4K
  • SRM 21.0M
  • Earning Date
  • PHGE 08-13-2025
  • SRM 08-11-2025
  • Dividend Yield
  • PHGE N/A
  • SRM N/A
  • EPS Growth
  • PHGE N/A
  • SRM N/A
  • EPS
  • PHGE N/A
  • SRM N/A
  • Revenue
  • PHGE N/A
  • SRM $4,394,659.00
  • Revenue This Year
  • PHGE N/A
  • SRM N/A
  • Revenue Next Year
  • PHGE N/A
  • SRM N/A
  • P/E Ratio
  • PHGE N/A
  • SRM N/A
  • Revenue Growth
  • PHGE N/A
  • SRM N/A
  • 52 Week Low
  • PHGE $0.34
  • SRM $0.26
  • 52 Week High
  • PHGE $3.86
  • SRM $12.80
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 39.46
  • SRM 58.88
  • Support Level
  • PHGE $0.42
  • SRM $6.42
  • Resistance Level
  • PHGE $0.47
  • SRM $8.58
  • Average True Range (ATR)
  • PHGE 0.05
  • SRM 1.56
  • MACD
  • PHGE 0.00
  • SRM -0.22
  • Stochastic Oscillator
  • PHGE 47.00
  • SRM 15.73

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

About SRM SRM Entertainment Inc.

SRM Entertainment Inc is a trusted toy and souvenir designer and developer, selling into theme parks and entertainment venues. It has developed, manufactured, and supplied the entertainment and amusement park industry with exclusive products that are often only available to consumers inside SRM's customer base venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld, Six Flags, Great Wolf Lodge, Dollywood, and Merlin Entertainment. Its product category includes The Smurfs and Zoonicorns, Sammy Sloth, lilita Llama, kyle Koala, and Hanna Hedgehog.

Share on Social Networks: